Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Prospective follow-up of 838 fetuses conceived after ovarian stimulation with corifollitropin alfa: comparative and overall neonatal outcome.

Bonduelle M, Mannaerts B, Leader A, Bergh C, Passier D, Devroey P.

Hum Reprod. 2012 Jul;27(7):2177-85. doi: 10.1093/humrep/des156. Epub 2012 May 15.

PMID:
22587997
[PubMed - indexed for MEDLINE]
Free Article
2.

High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.

Fatemi HM, Doody K, Griesinger G, Witjes H, Mannaerts B.

Hum Reprod. 2013 Feb;28(2):442-52. doi: 10.1093/humrep/des389. Epub 2012 Nov 7.

PMID:
23136144
[PubMed - indexed for MEDLINE]
Free Article
3.

Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH.

Tarlatzis BC, Griesinger G, Leader A, Rombauts L, Ijzerman-Boon PC, Mannaerts BM.

Reprod Biomed Online. 2012 Apr;24(4):410-9. doi: 10.1016/j.rbmo.2012.01.005. Epub 2012 Jan 24.

PMID:
22386594
[PubMed - indexed for MEDLINE]
4.

Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.

Fauser BC, Alper MM, Ledger W, Schoolcraft WB, Zandvliet A, Mannaerts BM; Engage Investigators.

Reprod Biomed Online. 2010 Nov;21(5):593-601. doi: 10.1016/j.rbmo.2010.06.032. Epub 2010 Jun 30.

PMID:
20843746
[PubMed - indexed for MEDLINE]
5.

A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone.

Boostanfar R, Mannaerts B, Pang S, Fernandez-Sanchez M, Witjes H, Devroey P; Engage Investigators.

Fertil Steril. 2012 Jun;97(6):1351-8. doi: 10.1016/j.fertnstert.2012.02.038. Epub 2012 Mar 28.

PMID:
22459628
[PubMed - indexed for MEDLINE]
6.

Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction.

Croxtall JD, McKeage K.

BioDrugs. 2011 Aug 1;25(4):243-54. doi: 10.2165/11206890-000000000-00000. Review.

PMID:
21815699
[PubMed - indexed for MEDLINE]
7.

A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol.

Devroey P, Boostanfar R, Koper NP, Mannaerts BM, Ijzerman-Boon PC, Fauser BC; ENGAGE Investigators.

Hum Reprod. 2009 Dec;24(12):3063-72. doi: 10.1093/humrep/dep291. Epub 2009 Aug 14. Erratum in: Hum Reprod. 2014 May;29(5):1116-20.

PMID:
19684043
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis.

Mahmoud Youssef MA, van Wely M, Aboulfoutouh I, El-Khyat W, van der Veen F, Al-Inany H.

Fertil Steril. 2012 Apr;97(4):876-85. doi: 10.1016/j.fertnstert.2012.01.092. Epub 2012 Jan 23. Review. Erratum in: Fertil Steril. 2012 Jun;97(6):1479.

PMID:
22277766
[PubMed - indexed for MEDLINE]
9.

Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study.

Polyzos NP, De Vos M, Corona R, Vloeberghs V, Ortega-Hrepich C, Stoop D, Tournaye H.

Hum Reprod. 2013 May;28(5):1254-60. doi: 10.1093/humrep/det045. Epub 2013 Feb 26.

PMID:
23442756
[PubMed - indexed for MEDLINE]
Free Article
10.

Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women.

Corifollitropin alfa Ensure Study Group.

Reprod Biomed Online. 2010 Jul;21(1):66-76. doi: 10.1016/j.rbmo.2010.03.019. Epub 2010 Mar 28.

PMID:
20483664
[PubMed - indexed for MEDLINE]
11.

A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation.

Corifollitropin Alfa Dose-finding Study Group.

Hum Reprod. 2008 Nov;23(11):2484-92. doi: 10.1093/humrep/den288. Epub 2008 Aug 6.

PMID:
18684735
[PubMed - indexed for MEDLINE]
Free Article
12.

Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.

Devroey P, Fauser BC, Platteau P, Beckers NG, Dhont M, Mannaerts BM.

J Clin Endocrinol Metab. 2004 May;89(5):2062-70.

PMID:
15126522
[PubMed - indexed for MEDLINE]
13.

Neonatal outcome and congenital malformations in children born after ICSI with testicular or epididymal sperm: a controlled national cohort study.

Fedder J, Loft A, Parner ET, Rasmussen S, Pinborg A.

Hum Reprod. 2013 Jan;28(1):230-40. doi: 10.1093/humrep/des377. Epub 2012 Nov 15.

PMID:
23154066
[PubMed - indexed for MEDLINE]
Free Article
14.

In vitro fertilization and multiple pregnancies: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(18):1-63. Epub 2006 Oct 1.

PMID:
23074488
[PubMed]
Free PMC Article
15.

Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation.

Bonduelle M, OberyƩ J, Mannaerts B, Devroey P.

Hum Reprod. 2010 Jun;25(6):1433-40. doi: 10.1093/humrep/deq072. Epub 2010 Apr 8.

PMID:
20378616
[PubMed - indexed for MEDLINE]
Free Article
16.

Long-acting FSH versus daily FSH for women undergoing assisted reproduction.

Pouwer AW, Farquhar C, Kremer JA.

Cochrane Database Syst Rev. 2012 Jun 13;6:CD009577. doi: 10.1002/14651858.CD009577.pub2. Review.

PMID:
22696386
[PubMed - indexed for MEDLINE]
17.

Administration of corifollitropin alfa on Day 2 versus Day 4 of the cycle in a GnRH antagonist protocol: A randomized controlled pilot study.

Blockeel C, Polyzos NP, Derksen L, De Brucker M, Vloeberghs V, van de Vijver A, De Vos M, Tournaye H.

Hum Reprod. 2014 May 9. [Epub ahead of print]

PMID:
24813196
[PubMed - as supplied by publisher]
18.

A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.

Propst AM, Bates GW, Robinson RD, Arthur NJ, Martin JE, Neal GS.

Fertil Steril. 2006 Jul;86(1):58-63. Epub 2006 Jun 6.

PMID:
16753156
[PubMed - indexed for MEDLINE]
19.

Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study.

Polyzos NP, Devos M, Humaidan P, Stoop D, Ortega-Hrepich C, Devroey P, Tournaye H.

Fertil Steril. 2013 Feb;99(2):422-6. doi: 10.1016/j.fertnstert.2012.09.043. Epub 2012 Oct 16.

PMID:
23084565
[PubMed - indexed for MEDLINE]
20.

Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity.

Norman RJ, Zegers-Hochschild F, Salle BS, Elbers J, Heijnen E, Marintcheva-Petrova M, Mannaerts B; Trust Investigators.

Hum Reprod. 2011 Aug;26(8):2200-8. doi: 10.1093/humrep/der163. Epub 2011 May 27.

PMID:
21622693
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk